Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Agios Pharmaceuticals, Inc. - Common Stock (NQ:AGIO)

42.60 -0.19 (-0.43%)
Streaming Delayed Price Updated: 9:30 AM EDT, Jul 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,950
Open 42.93
Bid (Size) 42.05 (200)
Ask (Size) 43.42 (200)
Prev. Close 42.79
Today's Range 41.79 - 42.93
52wk Range 22.24 - 46.00
Shares Outstanding 58,951,469
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Here's Why Shares in Novo Nordisk Rival, Agios Pharmaceutical, Soared This Week ↗
An accelerated approval for Agios' key drug to treat sickle cell disease appears to be on the cards. 
Via The Motley Fool
News headline image
Here's Why Agios Pharmaceuticals Stock Soared Today (Hint: It's FDA-Related) ↗
The company received some good news on its most important drug today. 
Via The Motley Fool

Performance

YTD
+56.8%
+56.8%
1 Month
+51.4%
+51.4%
3 Month
+29.4%
+29.4%
6 Month
+51.3%
+51.3%
1 Year
+9.0%
+9.0%

More News

Read More
The market is filled with gapping stocks in Tuesday's session. ↗
Via Chartmill
News headline image
Agios Pharmaceuticals Touts Mitapivat Gains Despite Sickle Cell Pain Miss ↗
Via MarketBeat
Agios Pharmaceuticals (NASDAQ:AGIO) Q1 2026 Earnings Beat Drives Stock Rally ↗
Via Chartmill
Topics Earnings
Agios Pharmaceuticals Inc (NASDAQ:AGIO) Reports Q4 2025 Revenue Beat and Narrower Loss ↗
Via Chartmill
News headline image
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia
From Avanzanite Bioscience B.V. and Agios Pharmaceuticals, Inc.
Via Business Wire
News headline image
Agios Pharmaceuticals Touts Strong AQVESME Launch as Sickle Cell Filing Advances ↗
Via MarketBeat
News headline image
Here's Why Shares in Agios Pharmaceuticals Soared This Week (And What to Expect Next in 2026) ↗
Via The Motley Fool
News headline image
Agios (AGIO) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Why Agios Pharmaceuticals Stock Zoomed to a 13% Gain on Wednesday ↗
Via The Motley Fool
News headline image
Here's Why Agios Pharmaceuticals Stock Slumped This Week (And What Investors Have to Look Forward to in 2026) ↗
Via The Motley Fool
News headline image
Agios (AGIO) Q3 2024 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Agios (AGIO) Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Agios (AGIO) Q3 2025 Earnings Transcript ↗
Via The Motley Fool
Top movers analysis one hour before the close of the markets on 2026-04-20: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
Here's Why Agios Pharmaceuticals Crashed 23% Today ↗
Via The Motley Fool
What's going on in today's session ↗
Via Chartmill
These stocks are gapping in today's session ↗
Via Chartmill
News headline image
Why Is Agios Pharmaceuticals Stock Surging Tuesday Afternoon? ↗
Via Benzinga
News headline image
Why Agios Pharmaceuticals Stock Is Up More Than 21% Today ↗
Via The Motley Fool
News headline image
Insider Sells AGIO Shares Worth $82,000 -- But Context Is Everything ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
From Sizable Stake to Zero: The Likely Reason Why Agios Shares Lost a $94 Million Backer ↗
Via The Motley Fool
News headline image
Agios Stock Down 16% in a Year as Fund Cuts Stake by $5.6 Million After 50% November Crash ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Agios (AGIO) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings

Frequently Asked Questions

Is Agios Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Agios Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Agios Pharmaceuticals, Inc. - Common Stock trade on?
Agios Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Agios Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Agios Pharmaceuticals, Inc. - Common Stock is AGIO on the Nasdaq Stock Market
What is the current price of Agios Pharmaceuticals, Inc. - Common Stock?
The current price of Agios Pharmaceuticals, Inc. - Common Stock is 42.60
When was Agios Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Agios Pharmaceuticals, Inc. - Common Stock was at 07/10/26 09:30 AM ET
What is the market capitalization of Agios Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Agios Pharmaceuticals, Inc. - Common Stock is 2.51B
How many shares of Agios Pharmaceuticals, Inc. - Common Stock are outstanding?
Agios Pharmaceuticals, Inc. - Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.